Indefinite Delivery Contract SPE2DU25D8015

Award Date 7/1/25
Last Date to Order 3/26/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) to Cardinal Health, Inc. for the provision of pharmaceutical and related medical products. The contract, valued at up to $4,999,999, is a single-award IDC with a base period of 30 months and three 30-month option periods, for a total potential period of performance through March 2036. The IDC is part of the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V)...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a large for-profit healthcare services and products company. The contract, valued at $999,999,999.00, is for the provision of pharmaceutical products and supplies to military treatment facilities and deployed troops worldwide under the DLA's Pharmaceutical Prime Vendor program. The contract does not utilize any set-asides. Through this IDC, Cardinal Health has received numerous...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) to Cardinal Health, Inc. to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers. The single-award IDC, valued at up to $4,999,999.00, has a 30-month base period with three 30-month option periods, for a total potential period of performance through March 2036. The IDC aims to establish Prime Vendor Contracts for the Pharmaceutical Prime...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company, to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency (DHA), U.S. Coast Guard, and U.S. Naval Fleet. The single-award IDC has a $4,999,999.00 ceiling value and a 30-month base period with three 30-month option periods, for a total estimated value of $30.3...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company, to provide a wide range of pharmaceutical and medical supplies to the U.S. federal government. The single-award IDC has a ceiling value of $9,999,999,999.00 and a period of performance through May 31, 2015. Cardinal Health delivers products such as antibiotics, pain medications, vaccines, radiopharmaceuticals, and specialty drugs...
The subject indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Cardinal Health, Inc., a global healthcare services and products company, to provide pharmaceutical support to various Department of Defense (DoD) customers worldwide. The single-award IDC has a 30-month base period and three 30-month option periods, with a total estimated value of $4,999,999.00. The contract aims to establish a Pharmaceutical Prime Vendor Global...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Cardinal Health, Inc., a global healthcare services and products company, to provide pharmaceutical support to various Department of Defense (DoD) customers worldwide. The contract has a 30-month base period and three 30-month option periods, with an estimated total value of $4,999,999.00. The purpose of this acquisition is for DLA Troop Support to establish Prime...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) to Cardinal Health, Inc. for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency (DHA), United States Coast Guard, and US Naval Fleet. The $4,999,999.00 single-award IDC has a 30-month base period and three 30-month option...
The federal contract IDV award to Cardinal Health, Inc. is a single-award Indefinite Delivery Contract (IDC) valued at $76,117,431.74 with a period of performance from March 7, 2025, to March 6, 2035. The contract is with the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain, a defense agency, to provide pharmaceutical (brand, generic, specialty) and pharmaceutical-related products worldwide to the Department of Defense (DoD), United States Coast Guard, and other designated...
The federal contract IDV award to Cardinal Health, Inc. is for a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract, valued at up to $999,999,999.00, with the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain as the funding agency. This single-award, indefinite delivery contract is intended to provide worldwide pharmaceutical support, including brand, generic, and specialty pharmaceuticals, to the Department of Defense (DoD), United States Coast Guard,...

This single-award indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Cardinal Health, Inc. to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency (DHA), U.S. Coast Guard, and U.S. Naval Fleet.

The $999,999,999.00 IDC has a 30-month base period and three 30-month option periods, for a total potential period of performance through March 2036. As the prime contractor, Cardinal Health will be responsible for furnishing pharmaceutical products, including brand, generic, and specialty drugs, to support normal day-to-day operations as well as planned and unplanned contingencies. The contract was awarded on a lowest price technically acceptable (LPTA) basis, with the government reserving the right to use a reverse auction to determine the final distribution fees. This unrestricted, fully competitive acquisition aims to ensure resiliency and access to vital pharmaceuticals for DoD healthcare facilities globally.

Generated 6/6/25, 9:43 AM